Chitosan oligosaccharide derivative increases accessibility of CpG to intestinal mucosal immune system and improves therapy efficacy of colorectal cancer vaccine
Chitosan oligosaccharide derivative increases accessibility of CpG to intestinal mucosal immune system and improves therapy efficacy of colorectal cancer vaccine. // BJA Open. – URL: https://www.sciencedirect.com/science/article/pii/S0142961226008070?dgcid=rss_sd_all
Chitosan oligosaccharide derivative increases accessibility of CpG to intestinal mucosal immune system and improves therapy efficacy of colorectal cancer vaccine. BJA Open. https://www.sciencedirect.com/science/article/pii/S0142961226008070?dgcid=rss_sd_all
“Chitosan oligosaccharide derivative increases accessibility of CpG to intestinal mucosal immune system and improves therapy efficacy of colorectal cancer vaccine.” BJA Open.
@article{article4408,
title = {Chitosan oligosaccharide derivative increases accessibility of CpG to intestinal mucosal immune system and improves therapy efficacy of colorectal cancer vaccine},
journal = {BJA Open},
url = {https://www.sciencedirect.com/science/article/pii/S0142961226008070?dgcid=rss_sd_all}
}